Skip to main content
. 2022 Nov 2;119(47):e2213361119. doi: 10.1073/pnas.2213361119

Fig. 3.

Fig. 3.

Levels of anti-PF4 antibodies according to various demographic and clinical parameters in hospitalized patients with COVID-19. (AD) Shown are the levels of anti-PF4 antibodies in hospitalized patients with COVID-19 analyzed according to sex (A), ethnic origin (B), age (C), and BMI (D). The statistical differences reported on the top for the indicated groups were evaluated by unpaired, two-tailed t tests; the other comparisons were not statistically significant.